Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ticagrelor CytoSorb Hemoadsorption (TISORB): Prospective, Open, Multi-center, Single-arm Study to Demonstrate the Feasibility of the CytoSorb® 300 mL Device to Remove Ticagrelor During Cardiopulmonary Bypass in Patients on Ticagrelor Undergoing Emergent or Urgent Cardiothoracic Surgery

NCT04131959 is registered in ClinicalTrials.gov with CytoSorbents, Inc as lead sponsor.

NCT NCT04131959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04131959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ticagrelor CytoSorb Hemoadsorption (TISORB): Prospective, Open, Multi-center, Single-arm Study to Demonstrate the Feasibility of the CytoSorb® 300 mL Device to Remove Ticagrelor During Cardiopulmonary Bypass in Patients on Ticagrelor Undergoing Emergent or Urgent Cardiothoracic Surgery
Lead sponsor
CytoSorbents, Inc
Phase
Not applicable
Overall status
Terminated
Start date
October 29, 2019
Completion date
May 4, 2021
Enrollment
5 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, drug removal, emergent cardiothoracic surgery